Benlysta (Belimumab)

Benlysta (Belimumab) is a biologic medicine that is used to treat lupus. It works by suppressing part of the body's immune system.

Benlysta inhibits a type of signalling protein (called a cytokine) that works to activate a type of white blood cell called the B-cell.

Taking Benlysta

Benlysta is given as an intravenous infusion (IV) by a trained nurse in a clinic.

The manufacturer of Benlysta offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks

Science

Safety

Drug Identification Number (DIN)

02370050 (IV)

02370069 (IV)